Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
26 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Microbial Resource Management Health from Gent, company number BE0742910132, closed financial year 2025 with a result of € -9.5 million after tax. For that financial year Microbial Resource Management Health recorded a gross margin of € 814,142 and equity of € 6.9 million. Compared with financial year 2024, the result moved from € -8.5 million to € -9.5 million. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.
€ 6.9 million
▲ € 18.5 million vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -9.5 million
▼ 13 % more loss than in 2024
Profit after tax over the fiscal year.
€ 8.1 million
▲ € 7.2 million vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -29.8 million.
People and assets in 2025
22.8
▼ 7.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 2.2 million
▼ 23% vs 2024
€ 94,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 44,838
▼ 26% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 278,945
▼ 98% vs 2024
€ 227,376 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.
€ 4.2 million
▲ 229% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 164,881
▼ 48% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -1,699,106 | € -4,105,484 | € -4,149,686 | € 814,142 | ▲ € 5 million |
| Profit after taxes | € -4,478,438 | € -7,456,158 | € -8,462,108 | € -9,525,921 | ▼ € 1.1 million |
| Equity | € 4,377,407 | € -3,078,751 | € -11,540,859 | € 6,931,978 | ▲ € 18.5 million |
| Total debts | € 3,512,678 | € 11,678,892 | € 15,267,766 | € 4,777,517 | ▼ 69% |
| Cash | € 3,311,746 | € 2,506,677 | € 886,342 | € 8,131,367 | ▲ € 7.2 million |
| Retained profit | € -4,333,468 | € -11,789,626 | € -20,251,734 | € -29,777,655 | ▼ € 9.5 million |
| Bank debt | € 188,296 | € 8,317,667 | € 12,049,583 | € 278,945 | ▼ 98% |
| Balance sheet total | € 7,890,085 | € 8,600,140 | € 3,726,907 | € 11,709,496 | ▲ 214% |
| Employees (FTE) | 25.5 | 29.4 | 30.2 | 22.8 | ▼ 7.4 |
Key figures of Microbial Resource Management Health, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Microbial Resource Management Health?
What happened at Microbial Resource Management Health in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Lenny Van Steenhuyse stepped down as director. NBB
- Julian Zachman stepped down as director. NBB
- Jean-Patrick Hennebelle stepped down as director. NBB
- Federale Participatie- En Investeringsmaatschappij stepped down as director. NBB
- Sam Possemiers stepped down as director. NBB
- David Devigne stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 9.5 million. Source: NBB ↗
- Lenny Van Steenhuyse became a director. NBB
In short
From € 4.5 million loss in 2022 to € 9.5 million loss in 2025.
Paid € 3,098 in corporate taxes since 2022.
On average € 35,700 of value added per employee in 2025.
A new publication or filing at Microbial Resource Management Health? We notify you, reason included.
Follow Microbial Resource Management HealthDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Microbial Resource Management Technologies, ACKERMANS & VAN HAAREN, FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ, QBIC II FUND ARKIV comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Microbial Resource Management HealthThe shares are held by Microbial Resource Management Technologies (57%), ACKERMANS & VAN HAAREN (17.2%), FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ (13.1%) and QBIC II FUND ARKIV (6.3%).
Directors
According to the 2025 annual accounts
Lenny Van Steenhuyse
Director
since 2025 · until 2031
Julian Zachman
Director
since 2025 · until 2031
Jean-Patrick Hennebelle
Director
since 2025 · until 2031
Federale Participatie- En Investeringsmaatschappij
Director · represented by Goedele Ertveldt
Also active at: Aviapartner Belgium, Société Anonyme Belge de Constructions Aéronautiques, Société Nationale de Construction Aérospatiale, COMETSAMBRE, ASCO INDUSTRIES, ZEPHYR - FIN, Sabena Aerospace Engineering, reMYND +57 more
since 2025 · until 2031
Sam Possemiers
Director
Also active at: Microbial Resource Management Technologies, ProDigest, NutriMax
since 2025 · until 2031
David Devigne
Director
Also active at: reMYND, Microbial Resource Management Technologies, ONTOFORCE
since 2025 · until 2031
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Technologiepark-Zwijnaarde 82
9052 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 26 companies are registered at this address.
All companies at this address →CONTREL EUROPE
€ 250,724 gross margin · 2025
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT
€ 1.4 million gross margin · 2025
VP VENTURES
€ -1,670 gross margin · 2025
SENSNET
Inbiose same network
€ 6.3 million revenue · 2025
+21 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0742.910.132
- VAT number
- BE 0742.910.132
- Registered office
- Technologiepark-Zwijnaarde 82, 9052 Gent
- Names & denominations
- Microbial Resource Management Health · MRM Health
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 4 February 2020
- Peppol
- Active · Active since 2 Dec 2025
- Activities · NACE
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overige gespecialiseerde wetenschappelijke en technische activiteiten
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Organisatie van congressen en beurzen
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied